195457-70-6 Usage
Description
3'-TRIFLUOROMETHYLBIPHENYL-4-CARBOXYLIC ACID, also known as 4-(3-Trifluoromethylphenyl)benzoic acid, is an organic compound with a unique molecular structure featuring a trifluoromethyl group attached to a biphenyl ring and a carboxylic acid functional group. 3'-TRIFLUOROMETHYLBIPHENYL-4-CARBOXYLIC ACID is known for its potential applications in various chemical and pharmaceutical processes due to its specific chemical properties.
Uses
Used in Pharmaceutical Industry:
3'-TRIFLUOROMETHYLBIPHENYL-4-CARBOXYLIC ACID is used as a reagent for the synthesis of aryl-substituted aspartic acid and diaminopropionic acid derivatives. These derivatives serve as inhibitors of glutamate transporter EAAT-2 (Excitatory amino acid transporters 2), which play a crucial role in the regulation of glutamate levels in the brain. By inhibiting EAAT-2, these derivatives can potentially be used in the development of treatments for neurological disorders associated with glutamate dysregulation.
Check Digit Verification of cas no
The CAS Registry Mumber 195457-70-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,5,4,5 and 7 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 195457-70:
(8*1)+(7*9)+(6*5)+(5*4)+(4*5)+(3*7)+(2*7)+(1*0)=176
176 % 10 = 6
So 195457-70-6 is a valid CAS Registry Number.
195457-70-6Relevant articles and documents
PIPERIDIN-4-YL-AZETIDINE DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS
-
Paragraph 0307; 0308, (2013/05/08)
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds, and enantiomers, diastereomers, and pharmaceutically acceptable salts thereof, are represented by Formula (I) as follows: wherein Y, Z, and R are defined herein.
Amide bridged piphenyl or biazaphenyl derivatives
-
Page/Page column 25, (2008/06/13)
This invention is concerned with compounds of the formula wherein one of R5, R6 and R7 is and R1 to R13, X1, X2, m and n are defined in the description, and all pharmaceutically